Stay updated on Retroviral Vector and Prodrug for Brain Tumor Surgery Clinical Trial
Sign up to get notified when there's something new on the Retroviral Vector and Prodrug for Brain Tumor Surgery Clinical Trial page.

Latest updates to the Retroviral Vector and Prodrug for Brain Tumor Surgery Clinical Trial page
- CheckyesterdayNo Change Detected
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedFooter revision updated from v3.3.3 to v3.3.4; this is a minor UI/documentation update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check30 days agoChange DetectedAdded a centralized Locations section listing study sites by state (California, Michigan, New Jersey, Ohio, Washington) and removed the separate state location subsections.SummaryDifference0.6%

- Check59 days agoChange DetectedA note was added clarifying that PubMed-listed publications are automatically filled from PubMed and may not relate to the study, along with an update to the revision tag v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check66 days agoChange DetectedRemoval of a government funding and operating status banner from the page. This does not alter the study details, eligibility criteria, locations, or outcomes.SummaryDifference0.4%

- Check81 days agoChange DetectedNo significant changes detected between the old and new screenshots; the Study Details page content and structure remain the same.SummaryDifference0.3%

- Check109 days agoChange DetectedThe page now includes an operating-status notice and a version update to v3.2.0, while removing the previous v3.1.0 reference.SummaryDifference4%

Stay in the know with updates to Retroviral Vector and Prodrug for Brain Tumor Surgery Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Retroviral Vector and Prodrug for Brain Tumor Surgery Clinical Trial page.